The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Tumor immunity and autoimmunity induced by immunization with homologous DNA.
Open accessAbstract
The immune system can recognize self antigens expressed by cancer cells.Differentiation antigens are prototypes of these self antigens, being expressed by cancer cells and their normal cell counterparts.The tyrosinase family proteins are well characterized differentiation antigens recognized by antibodies and T cells of patients with melanoma.However, immune tolerance may prevent immunity directed against these antigens.Immunity to the brown locus protein, gp75/ tyrosinase-related protein-1, was investigated in a syngeneic mouse model.C57BL/6 mice, which are tolerant to gp75, generated autoantibodies against gp75 after immunization with DNA encoding human gp75 but not syngeneic mouse gp75.Priming with human gp75 DNA broke tolerance to mouse gp75.Immunity against mouse gp75 provided significant tumor protection.Manifestations of autoimmunity were observed, characterized by coat depigmentation.Rejection of tumor challenge required CD4 ϩ and NK1.1 ϩ cells and Fc receptor ␥ -chain, but depigmentation did not require these components.Thus, immunization with homologous DNA broke tolerance against mouse gp75, possibly by providing help from CD4 ϩ T cells.Mechanisms required for tumor protection were not necessary for autoimmunity, demonstrating that tumor immunity can be uncoupled from autoimmune manifestations.( J. Clin.Invest.1998.102: 1258-1264.)Key words: melanoma • differentiation • xenogeneic • tolerance • tyrosinase MethodsCell lines and tissue culture.B16F10/LM3 is a pigmented mouse melanoma cell line of C57BL/6 origin derived from the B16F10 line, which was kindly provided by Dr. Isaiah Fidler (M.D. Anderson Cancer Center, Houston, TX) (17).The B16F10/LM3 line was isolated after three passages as lung metastases in C57BL/6 mice (18).The mouse fibroblast cell line L929 was obtained from the American Type Culture Collection (Rockville, MD).Cell lines were grown in
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1185 · Cited by 550 · cited 2×
“These include mutations in CDK4, a cell cycle regulatory gene, and b-catenin, which participates in cell adhesion and growth (29, 30).”
Background
Cited by
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Immune surveillance in the skin: mechanisms and clinical consequences
Kupper, T. S., & Fuhlbrigge, R. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1310 · Cited by 805
B16 as a Mouse Model for Human Melanoma
Overwijk, W. W., & Restifo, N. P. (2000) · Current Protocols in Immunology · doi:10.1002/0471142735.im2001s39 · Cited by 434
Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C.-C., Carroll, M. W., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2982 · Cited by 381
Bergman, P. J., Camps-Palau, M. A., McKnight, J. A., Leibman, N. F., Craft, D. M., Leung, C., Liao, J., Riviere, I., Sadelain, M., Hohenhaus, A. E., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.027 · Cited by 298
Self-citationHuman tumor antigens for cancer vaccine development
Wang, R., & Rosenberg, S. A. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01331.x · Cited by 296
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways
Leitner, W. W., Hwang, L. N., deVeer, M. J., Zhou, A., Silverman, R. H., Williams, B. R. G., Dubensky, T. W., Ying, H., & Restifo, N. P. (2003) · Nature Medicine · doi:10.1038/nm813 · Cited by 269
DNA vaccination: antigen presentation and the induction of immunity
Shedlock, D. J., & Weiner, D. B. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.6.793 · Cited by 259
Ludewig, B., Ochsenbein, A. F., Odermatt, B., Paulin, D., Hengartner, H., & Zinkernagel, R. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.795 · Cited by 252
Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy
Fong, L., Brockstedt, D., Benike, C., Breen, J. K., Strang, G., Ruegg, C. L., & Engleman, E. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7150 · Cited by 252
Gardner, H. L., Fenger, J. M., & London, C. A. (2016) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-022114-110911 · Cited by 215
Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer
Cappello, P., Rolla, S., Chiarle, R., Principe, M., Cavallo, F., Perconti, G., Feo, S., Giovarelli, M., & Novelli, F. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.020 · Cited by 110
Metadata
- Authors
- Weber, L. W., Bowne, W. B., Wolchok, J. D., Srinivasan, R., Qin, J., Moroi, Y., Clynes, R., Song, P., Lewis, J. J., & Houghton, A. N.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-09-15
- Volume
- 102
- Issue
- 6
- Pages
- 1258-1264
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1974565005
- Cited by
- 228
- References
- 1
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.